Many high quality drugs are manufactured in India, and the sub-continent has become the largest generics manufacturing location in the world. But it also has a significant problem with counterfeit and substandard drugs. The enforcement of private rights (notably trademarks) must be given more support, both domestically and in international fora such as at WHO and with respect to the EU. Further, the Government of India should not sponsor and promote reports which contain much misleading information concerning drug quality in India. Worse, some state governments have been very lenient towards local counterfeiters. In some instances officials have been directly bribed, and nearly all courts throughout the country have considerable backlogs of cases – allowing traders of potentially lethal products left free to ply an odious trade.
to read the complete article select the link above